Elanco Animal Health Statistics
Total Valuation
ELAN has a market cap or net worth of $11.15 billion. The enterprise value is $14.85 billion.
| Market Cap | 11.15B |
| Enterprise Value | 14.85B |
Important Dates
The next confirmed earnings date is Friday, November 6, 2026, before market open.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ELAN has 499.62 million shares outstanding. The number of shares has decreased by -0.50% in one year.
| Current Share Class | 499.62M |
| Shares Outstanding | 499.62M |
| Shares Change (YoY) | -0.50% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 0.71% |
| Owned by Institutions (%) | 114.18% |
| Float | 495.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 18.59 |
| PS Ratio | 2.25 |
| Forward PS | 2.15 |
| PB Ratio | 1.69 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 29.78 |
| P/OCF Ratio | 18.29 |
| PEG Ratio | 1.44 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.89, with an EV/FCF ratio of 39.55.
| EV / Earnings | n/a |
| EV / Sales | 2.99 |
| EV / EBITDA | 14.89 |
| EV / EBIT | 44.09 |
| EV / FCF | 39.55 |
Financial Position
The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.64.
| Current Ratio | 2.05 |
| Quick Ratio | 0.91 |
| Debt / Equity | 0.64 |
| Debt / EBITDA | 3.92 |
| Debt / FCF | 11.17 |
| Interest Coverage | 1.25 |
Financial Efficiency
Return on equity (ROE) is -2.98% and return on invested capital (ROIC) is 3.29%.
| Return on Equity (ROE) | -2.98% |
| Return on Assets (ROA) | 1.56% |
| Return on Invested Capital (ROIC) | 3.29% |
| Return on Capital Employed (ROCE) | 2.90% |
| Weighted Average Cost of Capital (WACC) | 11.19% |
| Revenue Per Employee | $507,071 |
| Profits Per Employee | -$20,101 |
| Employee Count | 9,900 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 1.30 |
Taxes
In the past 12 months, ELAN has paid $33.00 million in taxes.
| Income Tax | 33.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.99% in the last 52 weeks. The beta is 1.68, so ELAN's price volatility has been higher than the market average.
| Beta (5Y) | 1.68 |
| 52-Week Price Change | +18.99% |
| 50-Day Moving Average | 24.06 |
| 200-Day Moving Average | 23.78 |
| Relative Strength Index (RSI) | 37.84 |
| Average Volume (20 Days) | 5,420,539 |
Short Selling Information
The latest short interest is 30.92 million, so 6.19% of the outstanding shares have been sold short.
| Short Interest | 30.92M |
| Short Previous Month | 36.00M |
| Short % of Shares Out | 6.19% |
| Short % of Float | 6.24% |
| Short Ratio (days to cover) | 3.83 |
Income Statement
In the last 12 months, ELAN had revenue of $5.02 billion and -$199.00 million in losses. Loss per share was -$0.41.
| Revenue | 5.02B |
| Gross Profit | 2.78B |
| Operating Income | 340.00M |
| Pretax Income | -166.00M |
| Net Income | -199.00M |
| EBITDA | 1.01B |
| EBIT | 340.00M |
| Loss Per Share | -$0.41 |
Balance Sheet
The company has $530.00 million in cash and $4.23 billion in debt, with a net cash position of -$3.70 billion or -$7.41 per share.
| Cash & Cash Equivalents | 530.00M |
| Total Debt | 4.23B |
| Net Cash | -3.70B |
| Net Cash Per Share | -$7.41 |
| Equity (Book Value) | 6.59B |
| Book Value Per Share | 13.19 |
| Working Capital | 1.95B |
Cash Flow
In the last 12 months, operating cash flow was $617.00 million and capital expenditures -$238.00 million, giving a free cash flow of $379.00 million.
| Operating Cash Flow | 617.00M |
| Capital Expenditures | -238.00M |
| Depreciation & Amortization | 667.00M |
| Net Borrowing | 12.00M |
| Free Cash Flow | 379.00M |
| FCF Per Share | $0.76 |
Margins
Gross margin is 55.36%, with operating and profit margins of 6.77% and -3.96%.
| Gross Margin | 55.36% |
| Operating Margin | 6.77% |
| Pretax Margin | -3.31% |
| Profit Margin | -3.96% |
| EBITDA Margin | 20.06% |
| EBIT Margin | 6.77% |
| FCF Margin | 7.55% |
Dividends & Yields
ELAN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 0.50% |
| Shareholder Yield | 0.50% |
| Earnings Yield | -1.76% |
| FCF Yield | 3.36% |
Analyst Forecast
The average price target for ELAN is $31.21, which is 39.89% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $31.21 |
| Price Target Difference | 39.89% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 6.28% |
| EPS Growth Forecast (3Y) | 15.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ELAN has an Altman Z-Score of 1.33 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.33 |
| Piotroski F-Score | 5 |